Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Pediatric Blood & Cancer
|
July 22, 2009
Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG)
Scott T Miller, Winfred C Wang, Rathi Iyer, et al.
Pediatric Blood & Cancer
|
July 12, 2011
Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia
Scott T Miller, Kathy Rey, Jin He, et al.
Clinical Biochemistry
|
November 6, 2012
Comparison of hematologic measurements between local and central laboratories: data from the BABY HUG trial
Ram Kalpatthi, Bruce Thompson, Ming Lu, et al.
Pediatrics
|
April 3, 2004
Is Chlamydia pneumoniae infection associated with stroke in children with sickle cell disease?
Meenakshi Goyal, Scott T Miller, Margaret R Hammerschlag, et al.
AJR. American Journal of Roentgenology
|
May 25, 2011
Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial
M Beth McCarville, Zhaoyu Luo, Xiangke Huang, et al.
Transfusion
|
July 19, 2012
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010
Scott T Miller, Hae-Young Kim, Debra L Weiner, et al.
Pediatrics
|
September 4, 2013
Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia
Winfred C Wang, Suzette O Oyeku, Zhaoyu Luo, et al.
Transfusion
|
September 26, 2003
DAK, a new low-incidence antigen in the Rh blood group system
Marion E Reid, Jill R Storry, Laima Sausais, et al.
Pediatric Blood & Cancer
|
December 23, 2011
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study
Jeffrey D Lebensburger, Scott T Miller, Thomas H Howard, et al.
American Journal of Hematology
|
July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial
Ofelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Pediatric Blood & Cancer
|
July 22, 2009
Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG)
Scott T Miller, Winfred C Wang, Rathi Iyer, et al.
Pediatric Blood & Cancer
|
July 12, 2011
Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia
Scott T Miller, Kathy Rey, Jin He, et al.
Clinical Biochemistry
|
November 6, 2012
Comparison of hematologic measurements between local and central laboratories: data from the BABY HUG trial
Ram Kalpatthi, Bruce Thompson, Ming Lu, et al.
Pediatrics
|
April 3, 2004
Is Chlamydia pneumoniae infection associated with stroke in children with sickle cell disease?
Meenakshi Goyal, Scott T Miller, Margaret R Hammerschlag, et al.
AJR. American Journal of Roentgenology
|
May 25, 2011
Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial
M Beth McCarville, Zhaoyu Luo, Xiangke Huang, et al.
Transfusion
|
July 19, 2012
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010
Scott T Miller, Hae-Young Kim, Debra L Weiner, et al.
Pediatrics
|
September 4, 2013
Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia
Winfred C Wang, Suzette O Oyeku, Zhaoyu Luo, et al.
Transfusion
|
September 26, 2003
DAK, a new low-incidence antigen in the Rh blood group system
Marion E Reid, Jill R Storry, Laima Sausais, et al.
Pediatric Blood & Cancer
|
December 23, 2011
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study
Jeffrey D Lebensburger, Scott T Miller, Thomas H Howard, et al.
American Journal of Hematology
|
July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial
Ofelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
Page
of 5